The association between risk of airflow limitation and serum uric acid measured at medical health check-ups
The prevalence of COPD and asthma is increasing all over the world; however, their morbidities are thought to be greatly underestimated because of unawareness of patients' conditions and respiratory symptoms. Spirometry is useful for the early detection of COPD and asthma with airflow limitatio...
Saved in:
| Published in | International journal of chronic obstructive pulmonary disease Vol. 12; pp. 1213 - 1219 |
|---|---|
| Main Authors | , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
New Zealand
Dove Medical Press Limited
01.01.2017
Dove Medical Press Ltd Dove Medical Press |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1178-2005 1176-9106 1178-2005 |
| DOI | 10.2147/COPD.S126249 |
Cover
| Abstract | The prevalence of COPD and asthma is increasing all over the world; however, their morbidities are thought to be greatly underestimated because of unawareness of patients' conditions and respiratory symptoms. Spirometry is useful for the early detection of COPD and asthma with airflow limitation (AL), although it is not yet widely used for screening in epidemiological and primary care settings. A simple predictive marker used in combination with spirometry for AL is expected to be established. In medical health check-ups, serum uric acid (s-UA) is measured when screening for gout and has recently been suggested to have an association with several respiratory disorders, including asthma and COPD. However, whether s-UA influences the development of AL remains unclear. Therefore, the aims of this study were to examine the relationship between AL and s-UA and to investigate s-UA as a potential auxiliary marker for predicting AL risk in medical health check-ups. A total of 8,662 subjects aged >40 years were included. They were administered a simple questionnaire and assessed using pulmonary function tests, blood pressure (BP) measurements, and blood samplings. One hundred and fifty-six subjects (1.8%) had AL, just 29% of whom had experienced respiratory symptoms. The subjects with AL had significantly higher s-UA levels compared with never-smoking subjects without AL. Forced expiratory volume in 1 second (FEV
) %predicted showed significant correlations with age, smoking index, body mass index (BMI), mean BP, white blood cells, hemoglobin A1c, s-UA, and high-density lipoprotein cholesterol. In multiple logistic regression analysis, s-UA, in addition to age, smoking index, respiratory symptoms, and BMI, was independently associated with AL. In conclusion, elevated s-UA levels, together with respiratory symptoms, high smoking index, and weight loss, may epidemiologically predict the development of AL risk. |
|---|---|
| AbstractList | The prevalence of COPD and asthma is increasing all over the world; however, their morbidities are thought to be greatly underestimated because of unawareness of patients' conditions and respiratory symptoms. Spirometry is useful for the early detection of COPD and asthma with airflow limitation (AL), although it is not yet widely used for screening in epidemiological and primary care settings. A simple predictive marker used in combination with spirometry for AL is expected to be established. In medical health check-ups, serum uric acid (s-UA) is measured when screening for gout and has recently been suggested to have an association with several respiratory disorders, including asthma and COPD. However, whether s-UA influences the development of AL remains unclear. Therefore, the aims of this study were to examine the relationship between AL and s-UA and to investigate s-UA as a potential auxiliary marker for predicting AL risk in medical health check-ups. A total of 8,662 subjects aged >40 years were included. They were administered a simple questionnaire and assessed using pulmonary function tests, blood pressure (BP) measurements, and blood samplings. One hundred and fifty-six subjects (1.8%) had AL, just 29% of whom had experienced respiratory symptoms. The subjects with AL had significantly higher s-UA levels compared with never-smoking subjects without AL. Forced expiratory volume in 1 second (FEV
) %predicted showed significant correlations with age, smoking index, body mass index (BMI), mean BP, white blood cells, hemoglobin A1c, s-UA, and high-density lipoprotein cholesterol. In multiple logistic regression analysis, s-UA, in addition to age, smoking index, respiratory symptoms, and BMI, was independently associated with AL. In conclusion, elevated s-UA levels, together with respiratory symptoms, high smoking index, and weight loss, may epidemiologically predict the development of AL risk. Atsuro Fukuhara,1 Junpei Saito,1 Suguru Sato,1 Kazue Saito,1 Naoko Fukuhara,1 Yoshinori Tanino,1 Xintao Wang,1 Katsuaki Rinno,2 Hitoshi Suzuki,2 Mitsuru Munakata1 1Department of Pulmonary Medicine, School of Medicine, Fukushima Medical University, 2General Examination Center, Fukushima Preservation Service Association of Health, Fukushima, Japan Abstract: The prevalence of COPD and asthma is increasing all over the world; however, their morbidities are thought to be greatly underestimated because of unawareness of patients' conditions and respiratory symptoms. Spirometry is useful for the early detection of COPD and asthma with airflow limitation (AL), although it is not yet widely used for screening in epidemiological and primary care settings. A simple predictive marker used in combination with spirometry for AL is expected to be established. In medical health check-ups, serum uric acid (s-UA) is measured when screening for gout and has recently been suggested to have an association with several respiratory disorders, including asthma and COPD. However, whether s-UA influences the development of AL remains unclear. Therefore, the aims of this study were to examine the relationship between AL and s-UA and to investigate s-UA as a potential auxiliary marker for predicting AL risk in medical health check-ups. A total of 8,662 subjects aged >40years were included. They were administered a simple questionnaire and assessed using pulmonary function tests, blood pressure (BP) measurements, and blood samplings. One hundred and fifty-six subjects (1.8%) had AL, just 29% of whom had experienced respiratory symptoms. The subjects with AL had significantly higher s-UA levels compared with never-smoking subjects without AL. Forced expiratory volume in 1second (FEV1) %predicted showedsignificant correlations with age, smoking index, body mass index (BMI), mean BP, white blood cells, hemoglobin A1c, s-UA, and high-density lipoprotein cholesterol. In multiple logistic regression analysis, s-UA, in addition to age, smoking index, respiratory symptoms, and BMI, was independently associated with AL. In conclusion, elevated s-UA levels, together with respiratory symptoms, high smoking index, and weight loss, may epidemiologically predict the development of AL risk. Keywords: uric acid, airflow limitation, COPD, asthma, health check-up The prevalence of COPD and asthma is increasing all over the world; however, their morbidities are thought to be greatly underestimated because of unawareness of patients' conditions and respiratory symptoms. Spirometry is useful for the early detection of COPD and asthma with airflow limitation (AL), although it is not yet widely used for screening in epidemiological and primary care settings. A simple predictive marker used in combination with spirometry for AL is expected to be established. In medical health check-ups, serum uric acid (s-UA) is measured when screening for gout and has recently been suggested to have an association with several respiratory disorders, including asthma and COPD. However, whether s-UA influences the development of AL remains unclear. Therefore, the aims of this study were to examine the relationship between AL and s-UA and to investigate s-UA as a potential auxiliary marker for predicting AL risk in medical health check-ups. A total of 8,662 subjects aged >40 years were included. They were administered a simple questionnaire and assessed using pulmonary function tests, blood pressure (BP) measurements, and blood samplings. One hundred and fifty-six subjects (1.8%) had AL, just 29% of whom had experienced respiratory symptoms. The subjects with AL had significantly higher s-UA levels compared with never-smoking subjects without AL. Forced expiratory volume in 1 second ([FEV.sub.1]) %predicted showed significant correlations with age, smoking index, body mass index (BMI), mean BP, white blood cells, hemoglobin A1c, s-UA, and high-density lipoprotein cholesterol. In multiple logistic regression analysis, s-UA, in addition to age, smoking index, respiratory symptoms, and BMI, was independently associated with AL. In conclusion, elevated s-UA levels, together with respiratory symptoms, high smoking index, and weight loss, may epidemiologically predict the development of AL risk. Keywords: uric acid, airflow limitation, COPD, asthma, health check-up The prevalence of COPD and asthma is increasing all over the world; however, their morbidities are thought to be greatly underestimated because of unawareness of patients’ conditions and respiratory symptoms. Spirometry is useful for the early detection of COPD and asthma with airflow limitation (AL), although it is not yet widely used for screening in epidemiological and primary care settings. A simple predictive marker used in combination with spirometry for AL is expected to be established. In medical health check-ups, serum uric acid (s-UA) is measured when screening for gout and has recently been suggested to have an association with several respiratory disorders, including asthma and COPD. However, whether s-UA influences the development of AL remains unclear. Therefore, the aims of this study were to examine the relationship between AL and s-UA and to investigate s-UA as a potential auxiliary marker for predicting AL risk in medical health check-ups. A total of 8,662 subjects aged >40 years were included. They were administered a simple questionnaire and assessed using pulmonary function tests, blood pressure (BP) measurements, and blood samplings. One hundred and fifty-six subjects (1.8%) had AL, just 29% of whom had experienced respiratory symptoms. The subjects with AL had significantly higher s-UA levels compared with never-smoking subjects without AL. Forced expiratory volume in 1 second (FEV1) %predicted showed significant correlations with age, smoking index, body mass index (BMI), mean BP, white blood cells, hemoglobin A1c, s-UA, and high-density lipoprotein cholesterol. In multiple logistic regression analysis, s-UA, in addition to age, smoking index, respiratory symptoms, and BMI, was independently associated with AL. In conclusion, elevated s-UA levels, together with respiratory symptoms, high smoking index, and weight loss, may epidemiologically predict the development of AL risk. The prevalence of COPD and asthma is increasing all over the world; however, their morbidities are thought to be greatly underestimated because of unawareness of patients' conditions and respiratory symptoms. Spirometry is useful for the early detection of COPD and asthma with airflow limitation (AL), although it is not yet widely used for screening in epidemiological and primary care settings. A simple predictive marker used in combination with spirometry for AL is expected to be established. In medical health check-ups, serum uric acid (s-UA) is measured when screening for gout and has recently been suggested to have an association with several respiratory disorders, including asthma and COPD. However, whether s-UA influences the development of AL remains unclear. Therefore, the aims of this study were to examine the relationship between AL and s-UA and to investigate s-UA as a potential auxiliary marker for predicting AL risk in medical health check-ups. A total of 8,662 subjects aged >40 years were included. They were administered a simple questionnaire and assessed using pulmonary function tests, blood pressure (BP) measurements, and blood samplings. One hundred and fifty-six subjects (1.8%) had AL, just 29% of whom had experienced respiratory symptoms. The subjects with AL had significantly higher s-UA levels compared with never-smoking subjects without AL. Forced expiratory volume in 1 second (FEV1) %predicted showed significant correlations with age, smoking index, body mass index (BMI), mean BP, white blood cells, hemoglobin A1c, s-UA, and high-density lipoprotein cholesterol. In multiple logistic regression analysis, s-UA, in addition to age, smoking index, respiratory symptoms, and BMI, was independently associated with AL. In conclusion, elevated s-UA levels, together with respiratory symptoms, high smoking index, and weight loss, may epidemiologically predict the development of AL risk.The prevalence of COPD and asthma is increasing all over the world; however, their morbidities are thought to be greatly underestimated because of unawareness of patients' conditions and respiratory symptoms. Spirometry is useful for the early detection of COPD and asthma with airflow limitation (AL), although it is not yet widely used for screening in epidemiological and primary care settings. A simple predictive marker used in combination with spirometry for AL is expected to be established. In medical health check-ups, serum uric acid (s-UA) is measured when screening for gout and has recently been suggested to have an association with several respiratory disorders, including asthma and COPD. However, whether s-UA influences the development of AL remains unclear. Therefore, the aims of this study were to examine the relationship between AL and s-UA and to investigate s-UA as a potential auxiliary marker for predicting AL risk in medical health check-ups. A total of 8,662 subjects aged >40 years were included. They were administered a simple questionnaire and assessed using pulmonary function tests, blood pressure (BP) measurements, and blood samplings. One hundred and fifty-six subjects (1.8%) had AL, just 29% of whom had experienced respiratory symptoms. The subjects with AL had significantly higher s-UA levels compared with never-smoking subjects without AL. Forced expiratory volume in 1 second (FEV1) %predicted showed significant correlations with age, smoking index, body mass index (BMI), mean BP, white blood cells, hemoglobin A1c, s-UA, and high-density lipoprotein cholesterol. In multiple logistic regression analysis, s-UA, in addition to age, smoking index, respiratory symptoms, and BMI, was independently associated with AL. In conclusion, elevated s-UA levels, together with respiratory symptoms, high smoking index, and weight loss, may epidemiologically predict the development of AL risk. The prevalence of COPD and asthma is increasing all over the world; however, their morbidities are thought to be greatly underestimated because of unawareness of patients' conditions and respiratory symptoms. Spirometry is useful for the early detection of COPD and asthma with airflow limitation (AL), although it is not yet widely used for screening in epidemiological and primary care settings. A simple predictive marker used in combination with spirometry for AL is expected to be established. In medical health check-ups, serum uric acid (s-UA) is measured when screening for gout and has recently been suggested to have an association with several respiratory disorders, including asthma and COPD. However, whether s-UA influences the development of AL remains unclear. Therefore, the aims of this study were to examine the relationship between AL and s-UA and to investigate s-UA as a potential auxiliary marker for predicting AL risk in medical health check-ups. A total of 8,662 subjects aged >40 years were included. They were administered a simple questionnaire and assessed using pulmonary function tests, blood pressure (BP) measurements, and blood samplings. One hundred and fifty-six subjects (1.8%) had AL, just 29% of whom had experienced respiratory symptoms. The subjects with AL had significantly higher s-UA levels compared with never-smoking subjects without AL. Forced expiratory volume in 1 second ([FEV.sub.1]) %predicted showed significant correlations with age, smoking index, body mass index (BMI), mean BP, white blood cells, hemoglobin A1c, s-UA, and high-density lipoprotein cholesterol. In multiple logistic regression analysis, s-UA, in addition to age, smoking index, respiratory symptoms, and BMI, was independently associated with AL. In conclusion, elevated s-UA levels, together with respiratory symptoms, high smoking index, and weight loss, may epidemiologically predict the development of AL risk. |
| Audience | Academic |
| Author | Rinno, Katsuaki Sato, Suguru Munakata, Mitsuru Wang, Xintao Fukuhara, Atsuro Fukuhara, Naoko Tanino, Yoshinori Saito, Junpei Saito, Kazue Suzuki, Hitoshi |
| AuthorAffiliation | 1 Department of Pulmonary Medicine, School of Medicine, Fukushima Medical University 2 General Examination Center, Fukushima Preservation Service Association of Health, Fukushima, Japan |
| AuthorAffiliation_xml | – name: 1 Department of Pulmonary Medicine, School of Medicine, Fukushima Medical University – name: 2 General Examination Center, Fukushima Preservation Service Association of Health, Fukushima, Japan |
| Author_xml | – sequence: 1 givenname: Atsuro surname: Fukuhara fullname: Fukuhara, Atsuro – sequence: 2 givenname: Junpei surname: Saito fullname: Saito, Junpei – sequence: 3 givenname: Suguru surname: Sato fullname: Sato, Suguru – sequence: 4 givenname: Kazue surname: Saito fullname: Saito, Kazue – sequence: 5 givenname: Naoko surname: Fukuhara fullname: Fukuhara, Naoko – sequence: 6 givenname: Yoshinori surname: Tanino fullname: Tanino, Yoshinori – sequence: 7 givenname: Xintao surname: Wang fullname: Wang, Xintao – sequence: 8 givenname: Katsuaki surname: Rinno fullname: Rinno, Katsuaki – sequence: 9 givenname: Hitoshi surname: Suzuki fullname: Suzuki, Hitoshi – sequence: 10 givenname: Mitsuru surname: Munakata fullname: Munakata, Mitsuru |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28458533$$D View this record in MEDLINE/PubMed |
| BookMark | eNptksuL2zAQxk3Z0n20t56LoFB6qFNLlvW4FJb0tbCwhd2exViWEyWKlZXshv3vq6zTkISig4bxbz6Nv5nL7Kzzncmyt7iYEEz55-ndr6-Te0wYofJFdoExFzkpiursID7PLmNcpIBxjl9l50TQSlRleZEtH-YGQYxeW-it71Bt-o0xHQo2LpFvEdjQOr9Bzq5sPyLQNSiaMKzQEKxGoG2DVgbiEEyDoE9xYzU4NDfg-jnSc6OX-bCOr7OXLbho3uzuq-z3928P05_57d2Pm-n1ba4ZJX1ea2BCEgbAJSswqSQtmWCUy5YQTlpWY8m2WVxSohuQhvNaVDUvSmhZU5VX2c2o23hYqHWwKwhPyoNVzwkfZgpCb7UzSmBGCC6BUCwpMW1NqqYwTVFpbXDLyqSVj1pDt4anDTi3F8SF2g5Aab9uVBwHkPgvI78e6uSDNl0fwB01cfyls3M1839URQsiMU4CH3cCwT8OJvZqZaM2zkFn_BAVFrKUHDNaJPT9CbrwQ-iStYowLgWX5XNHO2oG6Ydt1_r0rt6KquuqxFIIQkWiJv-h0mnMyuq0ca1N-aOCDwcF46ijd8N2Q-Ix-O7Qkb0V_3YwAWQEdPAxBtMqvdu01IJ1e5-3i67u9z5_Oik6HcsR_hcIH_p5 |
| CitedBy_id | crossref_primary_10_1371_journal_pone_0285080 crossref_primary_10_1016_j_semarthrit_2017_11_004 crossref_primary_10_18410_jebmh_2019_522 crossref_primary_10_1186_s12902_022_00966_z crossref_primary_10_1371_journal_pone_0234363 crossref_primary_10_1097_MD_0000000000014507 crossref_primary_10_4103_atm_atm_305_23 crossref_primary_10_2147_COPD_S356797 crossref_primary_10_1038_s41598_019_50488_3 crossref_primary_10_1136_bmjresp_2022_001513 crossref_primary_10_1016_j_resinv_2019_01_005 crossref_primary_10_15384_kjhp_2019_19_4_196 crossref_primary_10_3389_fmed_2024_1416021 crossref_primary_10_1016_j_apmr_2021_08_026 crossref_primary_10_1177_0300060520983705 crossref_primary_10_18821_1560_9561_2020_23_4_223_228 crossref_primary_10_3390_antiox9050387 |
| ContentType | Journal Article |
| Copyright | COPYRIGHT 2017 Dove Medical Press Limited 2017. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2017 Fukuhara et al. This work is published and licensed by Dove Medical Press Limited 2017 |
| Copyright_xml | – notice: COPYRIGHT 2017 Dove Medical Press Limited – notice: 2017. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2017 Fukuhara et al. This work is published and licensed by Dove Medical Press Limited 2017 |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7RV 7X7 7XB 88E 8C1 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. KB0 M0S M1P NAPCQ PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI 7X8 5PM ADTOC UNPAY DOA |
| DOI | 10.2147/COPD.S126249 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Nursing & Allied Health Database Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Public Health Database ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ProQuest Health & Medical Collection Medical Database Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition MEDLINE - Academic PubMed Central (Full Participant titles) Unpaywall for CDI: Periodical Content Unpaywall DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Public Health ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic Publicly Available Content Database |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1178-2005 |
| EndPage | 1219 |
| ExternalDocumentID | oai_doaj_org_article_8162213a241942efb25d0ed05cce1f63 10.2147/copd.s126249 PMC5402911 A531988248 28458533 10_2147_COPD_S126249 |
| Genre | Journal Article |
| GeographicLocations | Japan |
| GeographicLocations_xml | – name: Japan |
| GroupedDBID | --- 0YH 29J 2WC 53G 5GY 5VS 7RV 7X7 88E 8C1 8FI 8FJ AAYXX ABUWG ADBBV ADRAZ AENEX AFKRA ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV BENPR C1A CCPQU CITATION CS3 DIK E3Z EBS EJD EMOBN F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR IHW INH INR ITC KQ8 M1P M48 M~E NAPCQ O5R O5S OK1 PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PSQYO PUEGO RNS RPM TDBHL TR2 UKHRP VDV CGR CUY CVF ECM EIF NPM PMFND 3V. 7XB 8FK AZQEC DWQXO K9. PKEHL PQEST PQQKQ PQUKI 7X8 5PM ADTOC UNPAY |
| ID | FETCH-LOGICAL-c642t-bca68926aa7960125943686479f2272f6b19625941342cda9e77b85b703af6d53 |
| IEDL.DBID | M48 |
| ISSN | 1178-2005 1176-9106 |
| IngestDate | Wed Aug 27 01:19:15 EDT 2025 Tue Aug 19 09:04:06 EDT 2025 Tue Sep 30 15:29:00 EDT 2025 Thu Sep 04 18:35:37 EDT 2025 Fri Jul 25 09:55:02 EDT 2025 Tue Jun 17 21:49:23 EDT 2025 Tue Jun 10 20:27:23 EDT 2025 Thu May 22 21:20:06 EDT 2025 Thu Jan 02 23:10:21 EST 2025 Thu Apr 24 23:07:36 EDT 2025 Wed Oct 01 03:49:06 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | airflow limitation asthma uric acid health check-up COPD |
| Language | English |
| License | http://creativecommons.org/licenses/by-nc/3.0 The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. cc-by-nc |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c642t-bca68926aa7960125943686479f2272f6b19625941342cda9e77b85b703af6d53 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.2147/COPD.S126249 |
| PMID | 28458533 |
| PQID | 2679879349 |
| PQPubID | 5500198 |
| PageCount | 7 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_8162213a241942efb25d0ed05cce1f63 unpaywall_primary_10_2147_copd_s126249 pubmedcentral_primary_oai_pubmedcentral_nih_gov_5402911 proquest_miscellaneous_1893971640 proquest_journals_2679879349 gale_infotracmisc_A531988248 gale_infotracacademiconefile_A531988248 gale_healthsolutions_A531988248 pubmed_primary_28458533 crossref_citationtrail_10_2147_COPD_S126249 crossref_primary_10_2147_COPD_S126249 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2017-01-01 |
| PublicationDateYYYYMMDD | 2017-01-01 |
| PublicationDate_xml | – month: 01 year: 2017 text: 2017-01-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | New Zealand |
| PublicationPlace_xml | – name: New Zealand – name: London |
| PublicationTitle | International journal of chronic obstructive pulmonary disease |
| PublicationTitleAlternate | Int J Chron Obstruct Pulmon Dis |
| PublicationYear | 2017 |
| Publisher | Dove Medical Press Limited Dove Medical Press Ltd Dove Medical Press |
| Publisher_xml | – name: Dove Medical Press Limited – name: Dove Medical Press Ltd – name: Dove Medical Press |
| References | 15612956 - Respirology. 2004 Nov;9(4):458-65 10631193 - Chest. 2000 Jan;117(1):19-24 18451345 - Stroke. 2008 Jul;39(7):1932-7 9847260 - Am J Respir Crit Care Med. 1998 Dec;158(6):1730-8 25542600 - Respir Investig. 2015 Jan;53(1):22-9 12412667 - Eur Respir J. 2002 Oct;20(4):799-805 22561964 - Am J Respir Crit Care Med. 2012 Jul 15;186(2):155-61 10191841 - J Gerontol A Biol Sci Med Sci. 1999 Mar;54(3):M136-9 12722324 - Nihon Kokyuki Gakkai Zasshi. 2003 Feb;41(2):74-80 12426272 - Chest. 2002 Nov;122(5):1686-94 17008642 - Am J Respir Crit Care Med. 2007 Jan 1;175(1):32-9 17550936 - Chest. 2007 Aug;132(2):403-9 18946066 - N Engl J Med. 2008 Oct 23;359(17):1811-21 20413537 - Eur Respir J. 2010 Dec;36(6):1259-69 21850198 - Int J Med Sci. 2011;8(6):470-8 9142060 - Lancet. 1997 May 3;349(9061):1269-76 17065352 - Diabetes. 2006 Nov;55(11):3127-32 21627570 - COPD. 2011 Aug;8(4):264-9 19931443 - Respir Med. 2010 Apr;104(4):550-6 8470901 - Arch Biochem Biophys. 1993 Apr;302(1):228-32 17294336 - Lung. 2007 Jan-Feb;185(1):21-4 24552242 - Am J Respir Crit Care Med. 2014 May 1;189(9):1022-30 17541218 - Intern Med. 2007;46(11):691-7 24904021 - Thorax. 2014 Nov;69(11):1021-6 19654543 - Curr Opin Nephrol Hypertens. 2009 Nov;18(6):526-30 16611654 - Eur Respir J. 2006 Sep;28(3):523-32 10419058 - J Hypertens. 1999 Jul;17(7):869-72 12801243 - Clin Sci (Lond). 2003 Oct;105(4):425-30 23645404 - Eur Respir J. 2014 Jan;43(1):43-53 22054035 - Respir Res. 2011 Nov 04;12:146 24641296 - Asian Pac J Allergy Immunol. 2014 Mar;32(1):93-9 23173592 - Curr Pharm Des. 2013;19(13):2432-8 16055882 - Eur Respir J. 2005 Aug;26(2):319-38 24827988 - PLoS One. 2014 May 14;9(5):e97646 18657959 - Respir Med. 2008 Nov;102(11):1568-74 15078751 - Chest. 2004 Apr;125(4):1394-9 14760151 - Thorax. 2004 Feb;59(2):120-5 16675214 - Respir Med. 2006 Dec;100(12):2170-6 |
| References_xml | – reference: 25542600 - Respir Investig. 2015 Jan;53(1):22-9 – reference: 17550936 - Chest. 2007 Aug;132(2):403-9 – reference: 23173592 - Curr Pharm Des. 2013;19(13):2432-8 – reference: 18451345 - Stroke. 2008 Jul;39(7):1932-7 – reference: 21850198 - Int J Med Sci. 2011;8(6):470-8 – reference: 24641296 - Asian Pac J Allergy Immunol. 2014 Mar;32(1):93-9 – reference: 23645404 - Eur Respir J. 2014 Jan;43(1):43-53 – reference: 15612956 - Respirology. 2004 Nov;9(4):458-65 – reference: 8470901 - Arch Biochem Biophys. 1993 Apr;302(1):228-32 – reference: 20413537 - Eur Respir J. 2010 Dec;36(6):1259-69 – reference: 19931443 - Respir Med. 2010 Apr;104(4):550-6 – reference: 22561964 - Am J Respir Crit Care Med. 2012 Jul 15;186(2):155-61 – reference: 15078751 - Chest. 2004 Apr;125(4):1394-9 – reference: 10631193 - Chest. 2000 Jan;117(1):19-24 – reference: 17065352 - Diabetes. 2006 Nov;55(11):3127-32 – reference: 12426272 - Chest. 2002 Nov;122(5):1686-94 – reference: 18946066 - N Engl J Med. 2008 Oct 23;359(17):1811-21 – reference: 16611654 - Eur Respir J. 2006 Sep;28(3):523-32 – reference: 14760151 - Thorax. 2004 Feb;59(2):120-5 – reference: 17008642 - Am J Respir Crit Care Med. 2007 Jan 1;175(1):32-9 – reference: 12412667 - Eur Respir J. 2002 Oct;20(4):799-805 – reference: 17541218 - Intern Med. 2007;46(11):691-7 – reference: 16675214 - Respir Med. 2006 Dec;100(12):2170-6 – reference: 9847260 - Am J Respir Crit Care Med. 1998 Dec;158(6):1730-8 – reference: 19654543 - Curr Opin Nephrol Hypertens. 2009 Nov;18(6):526-30 – reference: 12801243 - Clin Sci (Lond). 2003 Oct;105(4):425-30 – reference: 24904021 - Thorax. 2014 Nov;69(11):1021-6 – reference: 21627570 - COPD. 2011 Aug;8(4):264-9 – reference: 17294336 - Lung. 2007 Jan-Feb;185(1):21-4 – reference: 12722324 - Nihon Kokyuki Gakkai Zasshi. 2003 Feb;41(2):74-80 – reference: 16055882 - Eur Respir J. 2005 Aug;26(2):319-38 – reference: 9142060 - Lancet. 1997 May 3;349(9061):1269-76 – reference: 24827988 - PLoS One. 2014 May 14;9(5):e97646 – reference: 24552242 - Am J Respir Crit Care Med. 2014 May 1;189(9):1022-30 – reference: 10419058 - J Hypertens. 1999 Jul;17(7):869-72 – reference: 22054035 - Respir Res. 2011 Nov 04;12:146 – reference: 18657959 - Respir Med. 2008 Nov;102(11):1568-74 – reference: 10191841 - J Gerontol A Biol Sci Med Sci. 1999 Mar;54(3):M136-9 |
| SSID | ssj0056771 |
| Score | 2.2095013 |
| Snippet | The prevalence of COPD and asthma is increasing all over the world; however, their morbidities are thought to be greatly underestimated because of unawareness... Atsuro Fukuhara,1 Junpei Saito,1 Suguru Sato,1 Kazue Saito,1 Naoko Fukuhara,1 Yoshinori Tanino,1 Xintao Wang,1 Katsuaki Rinno,2 Hitoshi Suzuki,2 Mitsuru... |
| SourceID | doaj unpaywall pubmedcentral proquest gale pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 1213 |
| SubjectTerms | Adult Aged airflow limitation Asthma Asthma - diagnosis Asthma - epidemiology Asthma - physiopathology Biomarkers - blood Blood pressure Body mass index Cholesterol Chronic obstructive lung disease Complications and side effects COPD Creatinine Diagnosis Dyspnea Female Forced Expiratory Volume Hemoglobin High density lipoprotein Humans Hyperuricemia - blood Hyperuricemia - diagnosis Hyperuricemia - epidemiology Japan - epidemiology Lipoproteins Logistic Models Lung - physiopathology Male Measurement Methods Middle Aged Multivariate Analysis Odds Ratio Original Research Physiological aspects Predictive Value of Tests Prevalence Prognosis Proteins Pulmonary Disease, Chronic Obstructive - diagnosis Pulmonary Disease, Chronic Obstructive - epidemiology Pulmonary Disease, Chronic Obstructive - physiopathology Pulmonary function tests Pulmonary Ventilation Regression analysis Risk Factors Smoking Smoking - adverse effects Smoking - epidemiology Spirometry Surveys and Questionnaires Up-Regulation Uric acid Uric Acid - blood Weight Loss |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQD8AF8Sa0gJF4HFDUjWM7ybEUqgqpgASVerMmjq2umk1W3Y2q_ntm4mzYUCEuXOOJlHnPxOPPjL1RHvIUpI6rvNSx9F7ERe6zGKxTzgtsnPu7CE6-6uNT-eVMnW1d9UUzYQEeOAhuP0-0EEkKmGkKKZwvhapmrpopa13idY_ziWls00yFGKx0FlqtJOvtQIWRd7qTZ9-2SwxMidCC8DO3klGP2X8zMm-lpj_HJu90zRKur6Cut3LS0X12bygm-UFg4gG75ZqH7PbJsF3-iF2gEXD4rQA-TGVxGijnrecwv_R1e8VrOuYUSKCpOJplt-CEN8TBziu-CD8SKw5rvgg7OzwcoOSoc3sRd8vVY3Z69Pnn4XE83K4QW-w51nFpQeeF0AAZdjFY5xQERq9lVnghMuF1ic5JT5NUCltB4bKszFWJIQK8rlT6hO00beOe0XgUNkapglJYIa0XUIFzVurUSquUkxH7sBGzsQM7dANGbbAFIaWYw2_fP5kfQSkReztSLwPkxl_oPpLGRhoCyu4foPmYwXzMv8wnYq9I3yYIbXR3c0CxCbsPmUfsfU9BDo8fbWE4t4CsE3TWhHJvQomOaqfLG5syQ6BYGUG7YBgjiZ3X4zK9ScNvjWu7lUmwpiSkLzmL2NNggiPTWF1gw5ciH9nEOCdSma408_MeRhxrdYGpLmLvRjO-IW9yFjM4y_P_Ie9ddldQYdT_xNpjO-vLzr3Asm5dvuw9-BfbIUft priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9QwDI9gSMAL4pvCgCDx8YC6XdMkbZ_QGEwT0gAJJt1blOYDTrtrj_vQxH-P3eS6KxO8Nq6U2D87duLYhLwUXpe55jK1ZS1T7j1Lq9IXqTZOOM8gcO56EZx8lsen_NNYjOOB2zKmVW5sYmeobWvwjHyf4XUBgIlX7-a_UuwahbersYXGVXItA1cFUV2M-4BLyCIEXFkhQalHMiS-Y2ee_cMvXz_sfcuYZFhFc2tL6ir3X7bPWxvU38mTN9bNXP8-19Pp1s50dJvcii4lPQgYuEOuuOYuuX4SL83vkTOAAtUXYqAxN4tiWjltPdWThZ-253SKj50CiW4sBXCuZxSrDlFtJpbOwnGipXpFZ-F-h4ZnlBQkb87S9Xx5n5weffx-eJzGHgupgchjldZGy7JiUusCYhnwdiosSS95UXnGCuZlDSqKX7OcM2N15YqiLkUNhkJ7aUX-gOw0beMeYZIUhEe50DUzjBvPtNXOGS5zw40Qjifk7YbNysTlYB-MqYJABIWiUCgqCiUhr3rqeSi88Q-69yixngbLZXcf2sUPFbVPlZlkLMs1uCsVZ87XTNiRsyNhjMu8zBPyHOWtAtN6pVcHaKEgBuFlQt50FKj2MGmj4-sFWDoW0BpQ7g4oQV3NcHiDKRXNxVJdgDshL_ph_BNT4BrXrpcqA88S633xUUIeBgj2iwYfA8K-HNZRDMA54MpwpJn87IqJg8fOYMNLyOsexpf4bdq5VcvA78f_n_8TcpOh49MdUu2SndVi7Z6C27aqn3W6-QcNXD9v priority: 102 providerName: ProQuest |
| Title | The association between risk of airflow limitation and serum uric acid measured at medical health check-ups |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/28458533 https://www.proquest.com/docview/2679879349 https://www.proquest.com/docview/1893971640 https://pubmed.ncbi.nlm.nih.gov/PMC5402911 https://www.dovepress.com/getfile.php?fileID=36099 https://doaj.org/article/8162213a241942efb25d0ed05cce1f63 |
| UnpaywallVersion | publishedVersion |
| Volume | 12 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1178-2005 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0056771 issn: 1176-9106 databaseCode: KQ8 dateStart: 20060101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1178-2005 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0056771 issn: 1176-9106 databaseCode: KQ8 dateStart: 20090101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1178-2005 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0056771 issn: 1176-9106 databaseCode: DOA dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1178-2005 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0056771 issn: 1176-9106 databaseCode: DIK dateStart: 20060101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 1178-2005 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0056771 issn: 1176-9106 databaseCode: GX1 dateStart: 20060101 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1178-2005 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0056771 issn: 1176-9106 databaseCode: M~E dateStart: 20060101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 1178-2005 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0056771 issn: 1176-9106 databaseCode: RPM dateStart: 20060101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: http://www.proquest.com/pqcentral?accountid=15518 eissn: 1178-2005 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0056771 issn: 1176-9106 databaseCode: BENPR dateStart: 20140101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Proquest Health & Medical Complete customDbUrl: eissn: 1178-2005 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0056771 issn: 1176-9106 databaseCode: 7X7 dateStart: 20140101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: Public Health Database customDbUrl: eissn: 1178-2005 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0056771 issn: 1176-9106 databaseCode: 8C1 dateStart: 20140101 isFulltext: true titleUrlDefault: https://search.proquest.com/publichealth providerName: ProQuest – providerCode: PRVFZP databaseName: Scholars Portal Journals: Open Access customDbUrl: eissn: 1178-2005 dateEnd: 20250131 omitProxy: true ssIdentifier: ssj0056771 issn: 1176-9106 databaseCode: M48 dateStart: 20060301 isFulltext: true titleUrlDefault: http://journals.scholarsportal.info providerName: Scholars Portal – providerCode: PRVAWR databaseName: Taylor & Francis Open Access customDbUrl: eissn: 1178-2005 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0056771 issn: 1176-9106 databaseCode: 0YH dateStart: 20060101 isFulltext: true titleUrlDefault: https://www.tandfonline.com providerName: Taylor & Francis |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELf2IQEviG8CoxgJxgPKaBx_pA8IbWVThdQxAZXKU-Q4NlRLk64fGvvvuUvSsFCQeMlDfK1yd7-z7-zzHSEvhdNRqLn00yiRPneO-b3IKV8bK6xjEDiXvQiGp3Iw4h_HYrxF1vnztQAXfw3tsJ_UaJ4d_Ly4eg8G_w7TmAOu3vY_nX04-BIwCaHE_uzCx5ZSePRa99fYJruwTDGE_JA3RwxCqioaC1QJFVFlxW_8YWu9Ksv6b07e11avPzMrb67ymb661Fl2bdk6uUNu1_4mPawAcpds2fweuTGsT9Tvk3PACdW_dUTrxC2KOee0cFRP5i4rLmmGN6EqEp2nFJC7mlIsSUS1maR0Wu01plQv6bQ6_KHVHUsKsDDn_mq2eEBGJ8df-wO_bsDgGwhLln5itIx6TGqtINABV6iH9eolVz3HmGJOJmC_-DYIOTOp7lmlkkgkMItoJ1MRPiQ7eZHbx5hBBbFTKHTCDOPGMZ1qaw2XoeFGCMs98mYt5tjU7GCTjCyGKAWVEqNS4lopHnnVUM-qqhz_oDtCjTU0WEu7fFHMv8e1acZRIBkLQg0g6XFmXcJE2rVpVxhjAydDjzxHfceV0JoZIT7E6QsCFB555HVJgSiFjza6vtoArGN1rRblXosSbNm0h9eYitemEDM8KINpFNl50QzjLzE_LrfFahEH4HZiMTDe9cijCoIN0-CAQEwYAh-qBc6WVNoj-eRHWWkc3HkGq6FH9hsYb8jbFLM0XlTyfvIfH_iU3GLoGpXbWHtkZzlf2Wfg2C2TDtnufhvAU40VPKN-0CG7R8enZ5875VZJpzTgX6OiUEc |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELaqIlEuiDeBQo1E4YDSbhzHSQ4IlZZqS7sFiVbam3EcG1bdTZZ9aNU_xW9kJs6mGyq49RpPJHvm8zzs8QwhryOrklBx4edJJnxuLfPTxMa-0iYylkHgXPUi6J2K7jn_3I_6a-T38i0MplUudWKlqPNS4xn5LsPrAgATTz-Mf_nYNQpvV5ctNBwsjs3lAkK26fujA5DvNmOHn872u37dVcDX4GvP_EwrkaRMKBWD9w72PcUi7ILHqWUsZlZkAEr8GoSc6VylJo6zJMpgaygrcuwSASr_Fg87HGv1x_0mwItE7AK8IBagRDrCJdpjJ6Dd_S9fD3a-BUwwrNq5YgKrTgHX7cGKQfw7WXNjXozV5UINhyuW8PAeuVu7sHTPYe4-WTPFA3K7V1_SPyQXAD2qrsRO61wwimnstLRUDSZ2WC7oEB9XORJV5BQ2w3xEscoRVXqQ05E7vsypmtGRu0-i7tkmBaTpC38-nj4i5zfC_cdkvSgL8xSTsiAcCyOVMc24tkzlyhjNRai5jiLDPfJuyWap6-Vg342hhMAHhSJRKLIWike2G-qxK_TxD7qPKLGGBstzVx_KyQ9Z73aZBIKxIFTgHqWcGZuxKO-YvBNpbQIrQo9sobylY1qjZOQeakSIeXjikbcVBaoZmLRW9WsJWDoW7GpRbrYoQT3o9vASU7JWT1N5tZk88qoZxj8x5a4w5XwqA_Bksb4Y73jkiYNgs2jwaSDMDGEdcQucLa60R4rBz6p4OUQIDAysR940ML7Gb12Oczl1_H72__lvkY3uWe9EnhydHj8ndxg6XdUB2SZZn03m5gW4jLPsZbVPKfl-04rhDz02eak |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELemIQ1eEN8EBjMSgwcU2jiOkzwgNFaqjbExCSb1zTiODdXapPRD1f41_jru4jRrmOBtr_FFsu9-vg_7fEfIy8iqJFRc-HmSCZ9by_w0sbGvtImMZRA4V70Ijk_EwRn_NIgGG-T36i0MplWudGKlqPNS4xl5h-F1AYCJpx1bp0Wc9vrvJ7987CCFN62rdhoOIkfmYgnh2-zdYQ9kvctY_-O3_QO_7jDga_C7536mlUhSJpSKwZMHW59iQXbB49QyFjMrMgAofg1CznSuUhPHWRJlsE2UFTl2jAD1fyMOeYjpZPGgCfYiEbtgL4gFKJSucEn32BWos__ltPf2a8AEwwqea-aw6hpw1TasGce_EzdvLoqJuliq0WjNKvbvkNu1O0v3HP7ukg1T3CNbx_WF_X1yDjCk6hICtM4Lo5jSTktL1XBqR-WSjvChlSNRRU5hYyzGFCseUaWHOR27o8ycqjkdu7sl6p5wUkCdPvcXk9kDcnYt3H9INouyMI8xQQtCszBSGdOMa8tUrozRXISa6ygy3CNvVmyWul4O9uAYSQiCUCgShSJroXhkt6GeuKIf_6D7gBJraLBUd_WhnP6Q9c6XSSAYC0IFrlLKmbEZi_KuybuR1iawIvTIDspbOqY1CkfuoXaE-IcnHnldUaDKgUlrVb-cgKVj8a4W5XaLElSFbg-vMCVrVTWTlxvLIy-aYfwT0-8KUy5mMgCvFmuN8a5HHjkINosG_wZCzhDWEbfA2eJKe6QY_qwKmUO0wMDYeuRVA-Mr_NblJJczx-8n_5__DtkClSA_H54cPSW3GPpf1VnZNtmcTxfmGXiP8-x5tU0p-X7deuEPRG195A |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+association+between+risk+of+airflow+limitation+and+serum+uric+acid+measured+at+medical+health+check-ups&rft.jtitle=International+journal+of+chronic+obstructive+pulmonary+disease&rft.au=Fukuhara%2C+Atsuro&rft.au=Saito%2C+Junpei&rft.au=Sato%2C+Suguru&rft.au=Saito%2C+Kazue&rft.date=2017-01-01&rft.issn=1178-2005&rft.eissn=1178-2005&rft.volume=12&rft.spage=1213&rft_id=info:doi/10.2147%2FCOPD.S126249&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1178-2005&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1178-2005&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1178-2005&client=summon |